Speaker information: Paul Nyquist MD, MPH, is a Professor of Neurology, Anesthesia/Critical Care Medicine, and Neurosurgery, at Johns Hopkins School of Medicine. He has been a faculty there for over a decade. Dr Nyquist works in the Neurocritical unit and is a member of the Neurocritical care division at Johns Hopkins University Hospital. He is a clinician researcher and is part of an International community of Neurocritical Care, Stroke, and Intensive Care physicians. He has done work looking at extubation failure in the NCCU as well as the effects of ventilation in hospitalized patients with primary brain injury. He also is an expert on decompression illness and was a project officer at the Navy Medical Research Institute where he participated in key large human decompression trials such as the “1.3 at Heliox in human divers” and did seminal research on the effects of diving on complement activation in human divers. Academically, he is a Principal investigator on the silent stroke study in the Johns Hopkins GeneSTAR research group. He has developed or participated in large international genetic consortiums such as the NEUROCHARGE consortium, the International Stroke Genetics Consortium. He has participated in many large multi-centered international trials such as the SWISS, IMS3, FAST, and DIAS that are on the cutting edge of stroke intervention as a co-investigator or site PI. He has served in leadership roles in the Society of Critical Care Medicine as the chair of the Neuroscience section as well as other committees. He has been the ANA Neurocritical care SIG chair, he has been the AAN CCEN division Chair. He recently transitioned of the NCS executive committee and at Large member of the board of directors of the Neurocritical Care Society. He is presently the founding president of the Neurocritical Care Foundation.